Name: 글로벌 시장 동향
SKU: CD7788
Availability: InStock

보고서 요약(국문)

개요
글로벌 심장 진단 시장은 2022년 XX백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 XX%의 성장률로 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
심장 진단은 심장의 기능과 상태를 확인하기 위해 시행되는 검사입니다. 심장의 전기적 활동과 심장 박동 리듬에 대한 정보를 제공하고 심장의 비정상적인 활동을 파악하는 데 도움을 줍니다. 다양한 심혈관 질환을 식별하고 평가하며 질병 관리에 도움을 주는 것을 포함합니다.
심장 진단에 일반적으로 사용되는 검사에는 심전도, 홀터 모니터링, 심초음파 등이 있습니다. 심혈관 질환은 전 세계적으로 주요 사망 원인 중 하나입니다. 세계보건기구(WHO)에 따르면 매년 약 1,790만 명이 심혈관 질환으로 사망합니다. 이러한 질환에는 관상동맥 질환, 부정맥, 울혈성 심부전, 말초동맥 질환 등이 포함됩니다.
시장 동향: 동인 및 제약 요인
심혈관 질환 유병률 증가
심혈관 질환의 증가와 비만 인구 증가는 시장 성장을 견인할 것으로 예상됩니다. 예를 들어, 2023년 영국 심장 재단 보고서에 따르면 전 세계적으로 2억 명이 넘는 사람들이 관상동맥 질환을 앓고 있는 것으로 추산됩니다. 비만인 사람의 경우 지방이 동맥 벽을 막아 고혈압 위험을 높이고 혈액 공급을 방해하여 심장마비로 이어질 수 있습니다.
심장 질환 진단은 개인이 건강과 관련된 위험을 파악하는 데 도움이 됩니다. 예를 들어, 2021년 WHO 데이터에 따르면 6억 5천만 명이 넘는 성인이 비만으로 고통받고 있었습니다.

2021년 미국 국립보건원(NIH) 보고서에 따르면 전 세계 심방세동 유병률은 375억 7400만 건(전 세계 인구의 0.51%)으로, 지난 20년간 33% 증가했습니다. 따라서 위의 요인들이 예측 기간 동안 시장 성장을 견인할 것으로 예상됩니다.
또한 심혈관 질환 유병률 증가, 심장 질환에 대한 인식 제고, 그리고 기술 발전 또한 예측 기간 동안 시장 성장을 촉진할 것으로 전망됩니다.
심장 진단 절차 관련 부작용
심장 진단 절차 관련 부작용은 시장 성장을 저해할 것으로 예상됩니다. 심장 검사 후 주사로 인해 가려움증, 메스꺼움, 발진 등이 발생할 수 있습니다. 진행성 심장 질환 환자의 심장 스트레스 검사는 실신, 흉통, 부정맥, 심근경색을 유발할 수 있습니다. 따라서 위의 요인들은 시장 성장을 저해할 것으로 예상됩니다.
세분화 분석
전 세계 심장 진단 시장은 제품, 적용 분야, 최종 사용자 및 지역별로 세분화됩니다. 심전도(ECG) 시스템 부문은 시장 점유율의 약 56.3%를 차지했습니다.
심장 질환 환자 수 증가와 기술적으로 더욱 발전된 기기 출시 증가로 인해 심전도 시스템 제품군은 시장 점유율에서 주도적인 위치를 유지할 것으로 예상됩니다.
첨단 기기는 강력한 간섭 방지 및 부정맥 감지 기능을 갖추고 있습니다. 고급 기능을 탑재한 기기 출시 증가가 이 부문의 성장을 견인할 것으로 전망됩니다. 예를 들어, 2022년 10월 Dozee는 심혈관 질환(CVD) 환자 모니터링을 위한 휴대용 심전도(ECG) 패치를 출시했습니다. 이 기기는 환자가 이동 중에도 비정상적인 심박수와 리듬(부정맥)을 감지하여 원격으로 심장을 모니터링하는 데 유용합니다.
2021년 7월, 건강 모니터링 및 치료 기업인 OMRON Healthcare는 가정용 단일 리드 심전도(ECG) 및 혈압(BP) 모니터인 OMRON Complete를 출시했습니다. 따라서 기기 출시 증가로 인해 예측 기간 동안 해당 부문이 시장을 주도할 것으로 예상됩니다.
지역 분석
북미는 2022년 시장 점유율의 약 43.6%를 차지했습니다.
북미는 심장 질환 증가와 고령 인구 증가로 인해 예측 기간 동안 시장 점유율에서 주도적인 위치를 유지할 것으로 예상됩니다.
심장 질환은 미국에서 남녀를 불문하고 대부분의 인종 및 민족 집단에서 주요 사망 원인입니다. 예를 들어, 미국 심장 협회에 따르면 심혈관 질환(CVD)은 2020년 미국에서 928,741명의 사망자를 발생시킨 주요 사망 원인으로 추정됩니다.
또한, WHO의 2023년 보고서에 따르면 2021년 미국에서 심장 질환으로 사망한 사람은 약 695,000명으로, 전체 사망자의 5분의 1에 해당합니다.

2023년 심장 리듬 연합(Heart Rhythm Alliance)에 따르면 심방세동은 65세 미만 미국인 50명 중 1명, 65세 이상 미국인 10명 중 1명에게 영향을 미칩니다.
COVID-19 영향 분석
COVID-19는 감염 확산이 지속되면서 심장 진단 시장에 영향을 미쳤습니다. 팬데믹 정점 기간 동안 확진자 수가 급증하면서 심혈관 질환 진단 건수가 감소했지만, COVID-19의 긴급성으로 인해 진단 절차가 COVID-19 감염으로 전환되었습니다. 대부분의 진단 절차는 후기 단계로 연기되었습니다.

시장 세분화
제품별
• 심전도(ECG) 시스템
• 안정시 ECG 시스템
• 심폐 부하 검사 시스템
• 홀터 모니터링 장치
• 이벤트 모니터링 장치
• 이식형 루프 레코더(ILR)
• 기타
적용 분야별
• 심근경색
• 부정맥
• 허혈
• 심근 비대
• 기타
최종 사용자별
• 병원
• 외래 수술 센터
• 진단 영상 센터
• 전문 클리닉
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 스페인
o 이탈리아
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
주요 글로벌 업체 심장 진단 시장에는 GE Healthcare, BPL Medical Technologies, Boston Scientific Corporation, Abbott Laboratories, 3M Company, Koninklijke Philips N.V., Siemens Healthineers, Cardinal Health, Medtronic plc, Hitachi Medical Systems 등이 포함됩니다.
주요 개발 사항
• 2023년 6월, Eko Health는 차세대 디지털 청진기인 CORE 500을 출시했습니다. 이 제품은 진단 정확도를 높이고 질병을 조기에 발견할 수 있도록 인공지능(AI) 소프트웨어, 고음질 오디오, 풀컬러 디스플레이, 3리드 심전도(ECG) 기능을 결합했습니다.

• 2022년 2월, AliveCor는 일반 신용카드 크기의 심전도(ECG) 장치인 Kardia Mobile Card를 출시했습니다.

보고서 구매 이유

• 제품, 응용 분야, 최종 사용자 및 지역별 글로벌 심장 진단 시장 세분화를 시각화하고 주요 기업 및 주요 업체를 파악하기 위해. • 트렌드 분석 및 공동 개발을 통해 상업적 기회를 파악합니다.

• 모든 세그먼트를 포함한 심장 진단 시장 수준의 다양한 데이터가 담긴 엑셀 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 자료를 엑셀 파일로 제공합니다.

글로벌 심장 진단 시장 보고서는 약 62개의 표, 65개의 그림, 185페이지 분량입니다.
주요 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Cardiology Diagnostics Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030 growing at a CAGR of XX% during the forecast period 2023-2030.
Cardiology diagnostics are the tests that are performed to check the functioning of the heart and the condition of the heart. It gives information about the electrical activity of the heart, and heartbeat rhythm and helps to know the abnormal activity of the heart. It involves identifying and evaluating various cardiovascular diseases and helping manage the disease.
The tests that are normally involved in cardiology diagnostics are electrocardiogram, Holter monitoring, and echocardiogram among others. Cardiovascular diseases are among the leading causes of death worldwide. According to the World Health Organisation, an estimated 17.9 million lives annually. These diseases include coronary heart disease, arrhythmias, congestive heart failure, periphery artery disease, etc.
Market Dynamics: Drivers & Restraints
Increasing prevalence of cardiovascular diseases
Increasing cardiovascular diseases and an increase in the obese population are expected to drive market growth. For instance, according to the British Heart Foundation report in 2023, it is estimated that over 200 million people are with coronary heart disease all over the globe. In obese people the fatty material will clog the walls of the arteries which can increase the risk of high blood pressure and also the proper supply of blood will be clogged which leads to heart attacks.
The diagnosis of the condition of the heart helps the individual find the risks associated with the health. For instance, according to the WHO data in 2021, there were over 650 million adults suffering from obesity.
According to the report by NIH in 2021, the worldwide prevalence of atrial fibrillation is 37,574 million cases (0.51% of the worldwide population), which increased by 33% during the last 20 years. Thus, the above factors are expected to drive market growth during the forecast period.
Furthermore, the increase in the prevalence of cardiovascular diseases, increase in awareness among individuals about heart diseases, and increasing technological advancements are expected to drive the market growth during the forecast period.
Side effects associated with cardiology diagnostic procedures
The side effects associated with cardiology diagnostic procedures are expected to hinder the market growth. Occasionally after the heart scan people will experience itching, nausea, and rash sometimes due to the injection administered. Cardiac stress tests in advanced heart disease patients can cause fainting, chest pain, irregular heartbeat, and heart attack. Thus, the above factors are expected to hinder the market growth.
Segment Analysis
The global cardiology diagnostics are segmented based on product, application, end-user and region.
The Electrocardiogram (ECG) system segment accounted for approximately 56.3% of the market share
The Electrocardiogram system product segment is expected to hold the dominant position in the market share due to the increase in the number of patients with increasing heart problems and increasing technologically advanced device launches.
The advanced devices have strong abilities for anti-interference and arrhythmia detection. The increase in the number of device launches with advanced features is expected to drive the segment growth. For instance, in October 2022, Dozee launched an ambulatory electrocardiogram (ECG) patch to monitor patients with cardiovascular disease (CVD). The device will be useful for remote cardiac monitoring that detects abnormal heart rates and rhythms (arrhythmia) when the patient is ambulatory.
In July 2021, Health monitoring and therapy firm OMRON Healthcare launched OMRON Complete, its first single-lead electrocardiogram (ECG) and blood pressure (BP) monitor for home use. Thus, the increase in device launches is expected to hold the segment in the dominant position in the forecast period.
Geographical Analysis
North America accounted for approximately 43.6% of the market share in 2022
North America is expected to hold a dominant position in the market share during the forecast period due to the increasing heart diseases in the region and also the increasing geriatric population.
Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. For instance, according to the American Heart Association, it is estimated that cardiovascular disease (CVD) remains the leading cause of death in the United States which accounted for 928,741 deaths in the year 2020.
Furthermore, according to the report by WHO in 2023, it is estimated that about 695,000 people in the United States died from heart disease in 2021, which is 1 in every 5 deaths.
In 2023, Heart Rhythm Alliance stated that atrial fibrillation affects about 1 in 50 Americans under the age of 65 and about 1 in 10 Americans over age 65.
COVID-19 Impact Analysis
Covid 19 impacted the cardiology diagnostics market due to the continuous spread of the infection, increased number of cases during the peak of the pandemic led to a decrease in the diagnosis of cardiovascular diseases compared to covid 19 due to its emergency. There is a shift in the diagnostic procedures towards the covid 19 infection. Most of the procedures were postponed to later stages.

Market Segmentation
By Product
• Electrocardiogram (ECG) system
• Resting ECG Systems
• Cardiopulmonary Stress Testing Systems
• Holter Monitoring Devices
• Event Monitoring Devices
• Implantable Loop Recorder (ILR)
• Others
By Application
• Myocardial infarction
• Arrhythmia
• Ischemia
• Hypertrophy
• Others
By End User
• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Imaging Centers
• Specialty Clinics
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the cardiology diagnostics market include GE Healthcare, BPL Medical Technologies, Boston Scientific Corporation, Abbott Laboratories, 3M Company, Koninklijke Philips N.V., Siemens Healthineers, Cardinal Health, Medtronic plc, Hitachi Medical Systems among others.
Key Developments
• In June 2023, Eko Health launched its next-generation digital stethoscope, the CORE 500. It enhances diagnostic accuracy and early disease detection. It combines artificial intelligence (AI) software, high-fidelity audio, full-color display, and 3-lead electrocardiogram (ECG).
• In February 2022, AliveCor launched the Kardia Mobile Card, an electrocardiogram (ECG) device the size of a standard credit card.
Why Purchase the Report?
• To visualize the global cardiology diagnostics market segmentation based on product, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of cardiology diagnostics market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The global cardiology diagnostics market report would provide approximately 62 tables, 65 figures, and 185 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product
3.2. Snippet by Application
3.3. Snippet by End-user
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Driver
4.1.1.1. Increasing prevalence of cardiovascular diseases
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. Side Effects Associated with the Diagnostic Procedure
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Electrocardiogram (ECG) system*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Resting ECG Systems
7.4. Cardiopulmonary Stress Testing Systems
7.5. Holter Monitoring Devices
7.6. Event Monitoring Devices
7.7. Implantable Loop Recorder (ILR)
7.8. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Myocardial infarction*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Arrhythmia
8.4. Ischemia
8.5. Hypertrophy
8.6. Others
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Diagnostic Imaging Centers
9.5. Specialty Clinics
9.6. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. GE Healthcare
12.1.1. Company Overview
12.1.2. Product Type Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. BPL Medical Technologies
12.3. Boston Scientific Corporation
12.4. Abbott Laboratories
12.5. 3M Company
12.6. Koninklijke Philips N.V.
12.7. Siemens Healthineers
12.8. Cardinal Health
12.9. Medtronic plc
12.10. Hitachi Medical Systems.
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

GE Healthcare, 4.	Key Developments, BPL Medical Technologies, Boston Scientific Corporation, Abbott Laboratories, 3M Company, Koninklijke Philips N.V., Siemens Healthineers, Cardinal Health, Medtronic plc, Hitachi Medical Systems.

표 목록 (Tables)

List of Tables

Table 1 Global Cardiology Diagnostics Market Value, By Product, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Cardiology Diagnostics Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Cardiology Diagnostics Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Cardiology Diagnostics Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Cardiology Diagnostics Market Value, By Product, 2022-2031 (US$ Million)

Table 6 Global Cardiology Diagnostics Market Value, By Application, 2022-2031 (US$ Million)

Table 7 Global Cardiology Diagnostics Market Value, By End User, 2022-2031 (US$ Million)

Table 8 Global Cardiology Diagnostics Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 9 Global Cardiology Diagnostics Market Value, By Region, 2022-2031 (US$ Million)

Table 10 North America Cardiology Diagnostics Market Value, By Product, 2022-2031 (US$ Million)

Table 11 North America Cardiology Diagnostics Market Value, By Application, 2022-2031 (US$ Million)

Table 12 North America Cardiology Diagnostics Market Value, By , 2022-2031 (US$ Million)

Table 13 North America Cardiology Diagnostics Market Value, By , 2022-2031 (US$ Million)

Table 14 North America Cardiology Diagnostics Market Value, By End User, 2022-2031 (US$ Million)

Table 15 North America Cardiology Diagnostics Market Value, By Country, 2022-2031 (US$ Million)

Table 16 South America Cardiology Diagnostics Market Value, By Product, 2022-2031 (US$ Million)

Table 17 South America Cardiology Diagnostics Market Value, By Application, 2022-2031 (US$ Million)

Table 18 South America Cardiology Diagnostics Market Value, By , 2022-2031 (US$ Million)

Table 19 South America Cardiology Diagnostics Market Value, By , 2022-2031 (US$ Million)

Table 20 South America Cardiology Diagnostics Market Value, By End User, 2022-2031 (US$ Million)

Table 21 South America Cardiology Diagnostics Market Value, By Country, 2022-2031 (US$ Million)

Table 22 Europe Cardiology Diagnostics Market Value, By Product, 2022-2031 (US$ Million)

Table 23 Europe Cardiology Diagnostics Market Value, By Application, 2022-2031 (US$ Million)

Table 24 Europe Cardiology Diagnostics Market Value, By End User, 2022-2031 (US$ Million)

Table 25 Europe Cardiology Diagnostics Market Value, By Country, 2022-2031 (US$ Million)

Table 26 Asia-Pacific Cardiology Diagnostics Market Value, By Product, 2022-2031 (US$ Million)

Table 27 Asia-Pacific Cardiology Diagnostics Market Value, By Application, 2022-2031 (US$ Million)

Table 28 Asia-Pacific Cardiology Diagnostics Market Value, By End User, 2022-2031 (US$ Million)

Table 29 Asia-Pacific Cardiology Diagnostics Market Value, By Country, 2022-2031 (US$ Million)

Table 30 Middle East & Africa Cardiology Diagnostics Market Value, By Product, 2022-2031 (US$ Million)

Table 31 Middle East & Africa Cardiology Diagnostics Market Value, By Application, 2022-2031 (US$ Million)

Table 32 Middle East & Africa Cardiology Diagnostics Market Value, By End User, 2022-2031 (US$ Million)

Table 33 GE Healthcare: Overview

Table 34 GE Healthcare: Product Portfolio

Table 35 GE Healthcare: Key Developments

Table 36 BPL Medical Technologies: Overview

Table 37 BPL Medical Technologies: Product Portfolio

Table 38 BPL Medical Technologies: Key Developments

Table 39 Boston Scientific Corporation: Overview

Table 40 Boston Scientific Corporation: Product Portfolio

Table 41 Boston Scientific Corporation: Key Developments

Table 42 Abbott Laboratories: Overview

Table 43 Abbott Laboratories: Product Portfolio

Table 44 Abbott Laboratories: Key Developments

Table 45 3M Company : Overview

Table 46 3M Company : Product Portfolio

Table 47 3M Company : Key Developments

Table 48 Koninklijke Philips N.V.: Overview

Table 49 Koninklijke Philips N.V.: Product Portfolio

Table 50 Koninklijke Philips N.V.: Key Developments

Table 51 Siemens Healthineers: Overview

Table 52 Siemens Healthineers: Product Portfolio

Table 53 Siemens Healthineers: Key Developments

Table 54 Cardinal Health: Overview

Table 55 Cardinal Health: Product Portfolio

Table 56 Cardinal Health: Key Developments

Table 57 Medtronic plc: Overview

Table 58 Medtronic plc: Product Portfolio

Table 59 Medtronic plc: Key Developments

Table 60 Hitachi Medical Systems: Overview

Table 61 Hitachi Medical Systems: Product Portfolio

Table 62 Hitachi Medical Systems: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 2 Global Cardiology Diagnostics Market Share, By Product, 2022 & 2031 (%)

Figure 3 Global Cardiology Diagnostics Market Share, By Application, 2022 & 2031 (%)

Figure 4 Global Cardiology Diagnostics Market Share, By End User, 2022 & 2031 (%)

Figure 5 Global Cardiology Diagnostics Market Share, By Region, 2022 & 2031 (%)

Figure 6 Global Cardiology Diagnostics Market Y-o-Y Growth, By Product, 2022-2031 (%)

Figure 7 Electrocardiogram (ECG) system Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 8 Resting ECG Systems Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 9 Cardiopulmonary Stress Testing Systems Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 10 Holter Monitoring Devices Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 11 Event Monitoring Devices Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 12 Implantable Loop Recorder (ILR) Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 13 Others Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 14 Global Cardiology Diagnostics Market Y-o-Y Growth, By Application, 2022-2031 (%)

Figure 15 Myocardial infarction Application in Global Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 16 Arrhythmia Application in Global Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 17 Ischemia Application in Global Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 18 Hypertrophy Application in Global Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 19 Others Application in Global Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 20 Global Cardiology Diagnostics Market Y-o-Y Growth, By End User, 2022-2031 (%)

Figure 21 Hospitals in Global Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 22 Ambulatory Surgical Centers in Global Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 23 Diagnostic Imaging Centers in Global Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 24 Specialty Clinics in Global Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 25 Others in Global Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 26 Global Cardiology Diagnostics Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 27 North America Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 28 Asia-Pacific Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 29 Europe Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 30 South America Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 31 Middle East and Africa Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 32 North America Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 33 North America Cardiology Diagnostics Market Share, By Product, 2022 & 2031 (%)

Figure 34 North America Cardiology Diagnostics Market Share, By Application, 2022 & 2031 (%)

Figure 35 North America Cardiology Diagnostics Market Share, By End User, 2022 & 2031 (%)

Figure 36 North America Cardiology Diagnostics Market Share, By Country, 2022 & 2031 (%)

Figure 37 South America Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 38 South America Cardiology Diagnostics Market Share, By Product, 2022 & 2031 (%)

Figure 39 South America Cardiology Diagnostics Market Share, By Application, 2022 & 2031 (%)

Figure 40 South America Cardiology Diagnostics Market Share, By End User, 2022 & 2031 (%)

Figure 41 South America Cardiology Diagnostics Market Share, By Country, 2022 & 2031 (%)

Figure 42 Europe Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 43 Europe Cardiology Diagnostics Market Share, By Product, 2022 & 2031 (%)

Figure 44 Europe Cardiology Diagnostics Market Share, By Application, 2022 & 2031 (%)

Figure 45 Europe Cardiology Diagnostics Market Share, By End User, 2022 & 2031 (%)

Figure 46 Europe Cardiology Diagnostics Market Share, By Country, 2022 & 2031 (%)

Figure 47 Asia-Pacific Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 48 Asia-Pacific Cardiology Diagnostics Market Share, By Product, 2022 & 2031 (%)

Figure 49 Asia-Pacific Cardiology Diagnostics Market Share, By Application, 2022 & 2031 (%)

Figure 50 Asia-Pacific Cardiology Diagnostics Market Share, By End User, 2022 & 2031 (%)

Figure 51 Asia-Pacific Cardiology Diagnostics Market Share, By Country, 2022 & 2031 (%)

Figure 52 Middle East & Africa Cardiology Diagnostics Market Value, 2022-2031 (US$ Million)

Figure 53 Middle East & Africa Cardiology Diagnostics Market Share, By Product, 2022 & 2031 (%)

Figure 54 Middle East & Africa Cardiology Diagnostics Market Share, By Application, 2022 & 2031 (%)

Figure 55 Middle East & Africa Cardiology Diagnostics Market Share, By End User, 2022 & 2031 (%)

Figure 56 GE Healthcare: Financials

Figure 57 BPL Medical Technologies: Financials

Figure 58 Boston Scientific Corporation: Financials

Figure 59 Abbott Laboratories: Financials

Figure 60 3M Company : Financials

Figure 61 Koninklijke Philips N.V.: Financials

Figure 62 Siemens Healthineers: Financials

Figure 63 Cardinal Health: Financials

Figure 64 Medtronic plc: Financials

Figure 65 Hitachi Medical Systems: Financials

글로벌 심장 진단 시장 – 2023-2030

Global Cardiology Diagnostics Market - 2023-2030